Observational Study
Copyright ©The Author(s) 2024.
World J Psychiatry. Oct 19, 2024; 14(10): 1467-1473
Published online Oct 19, 2024. doi: 10.5498/wjp.v14.i10.1467
Table 2 Serum neutrophil gelatinase-associated lipocalin levels at admission in patients with and without cognitive impairment, anxiety, and depressive symptoms
Neuropsychiatric complication
Serum NGAL levels (ng/mL)
P value
Yes
No
Cognitive impairment, median (interquartile range)5.6 (4.2-7.1)3.2 (2.4-4.3)< 0.001
Anxiety, median (interquartile range)5.1 (3.8-6.6)3.5 (2.6-4.7)0.002
Depressive symptoms, median (interquartile range)5.4 (4.0-6.9)3.3 (2.5-4.5)< 0.001